KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
27,854
Total Value
$83,344.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 21, 2026 | Exercise/Conversion | 6,250 | โ | โ | 139,337 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 22, 2026 | Exercise/Conversion | 5,000 | โ | โ | 144,337 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 23, 2026 | Sale | 5,354 | $15.57 | $83,344.65 | 138,983 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Feb 21, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 75,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Feb 22, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 45,000 | Direct | โ | View Details |